Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

Any oncologists that would care to speak up here?

About this patient: prob followed for a while at Dana Farber- but of course I do not know this for sure. Therefore likely many checks of her CA-125 level, so there would have been some track record.

Let's ask the first 3 oncologists to respond- in widely metastatic ovarian cancer, in a patient with previously followed CA 125 levels, what is the most likely cause of a rise in biomarker? (Assuming no radiation- I think the article would have mentioned that)

I will ask people here at work the same thing.

Glad to admit ignorance if they think otherwise.